IMAAVY™
(nipocalimab-aahu)
IMAAVY™ (nipocalimab-aahu)
Pivotal clinical trial publications
Generalized myasthenia gravis (gMG)
VIVACITY-MG3
Antozzi C, Vu T, Ramchandren S, et al. Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2025;24(2):105-116. doi:10.1016/S1474-4422(24)00498-8